about
Drug Targets for Oxidative Podocyte Injury in Diabetic NephropathyOngoing clinical trials of the pleiotropic effects of statinsOpposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1.Renoprotective Effects of Atorvastatin in Diabetic Mice: Downregulation of RhoA and Upregulation of Akt/GSK3.Modulation of oxidative stress-induced changes in hypertension and atherosclerosis by antioxidantsRole of MutS homolog 2 (MSH2) in intestinal myofibroblast proliferation during Crohn's disease stricture formationEffects of Statins on Bone Mineral Density and Fracture Risk: A PRISMA-compliant Systematic Review and Meta-AnalysisStatins and colorectal cancer.NF-κB signaling and bone resorption.Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure.Mevastatin ameliorates sphingosine 1-phosphate-induced COX-2/PGE2-dependent cell migration via FoxO1 and CREB phosphorylation and translocation.Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery.The role of oxidative stress in postprandial endothelial dysfunction.Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease.Drug delivery to the ischemic brain.Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species.Antioxidant properties of drugs used in Type 2 diabetes management: could they contribute to, confound or conceal effects of antioxidant therapy?Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: the role of sirtuin 1 gene variants in human coronary atherosclerosis.Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formationSynergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide.Pravastatin improves the impaired nitric oxide-mediated neurogenic and endothelium-dependent relaxation of corpus cavernosum in aged rats.Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction.EPR studies on hydroxyl radical-scavenging activities of pravastatin and fluvastatin.[Effects of ramipril and simvastatin on the oxidative stress of diabetic rats].Melatonin synergistically enhances protective effect of atorvastatin against gentamicin-induced nephrotoxicity in rat kidney.Atorvastatin-mediated protection of the retina in a model of diabetes with hyperlipidemia.Magnesium tanshinoate B protects endothelial cells against oxidized lipoprotein-induced apoptosis.Atorvastatin improves erectile dysfunction in patients initially irresponsive to Sildenafil by the activation of endothelial nitric oxide synthase.Cellular death, reactive oxygen species (ROS) and diabetic complications.Statins and IL-1β, IL-10, and MPO Levels in Gingival Crevicular Fluid: Preliminary Results.Ameliorative effect of statin therapy on oxidative damage in heart tissue of hypercholesterolemic rabbits.Glycaemic control in type 2 diabetic patients with chronic kidney disease: the impacts on enzymatic antioxidants and soluble RAGE.The effect of atorvastatin treatment duration on oxidative stress markers and lipid profile in patients with coronary artery diseases: A case series study.Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α.Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation
P2860
Q26769787-8672440A-5A8B-4B93-A0C4-52AE4EC97FD6Q28219321-D0656D88-AD8F-4250-92BD-48285D106EA5Q36001631-3114B465-95AB-4FEB-B19A-8741CC657C20Q36138508-170476E5-F834-4C01-B538-60244BA0B372Q36511677-52A53A6C-2686-48BD-B49F-995950805E63Q36877267-7C678CF1-7747-423D-AFE3-F22514068B18Q36988655-CEF62D31-CF5C-43EB-A134-E0B4C47CCC62Q36988768-6B30D254-BD1D-4119-BDA8-FAD14B9709A8Q37449635-212B10B5-EBBE-4362-9167-24AC52AFA864Q37539268-650D3DE6-0B5C-4999-87C0-E866D1245DB4Q37686108-057EF50B-A238-4078-B23F-2D4292770776Q37695344-82B96CFC-7BDB-4390-AC80-6E16E7CCFF9DQ38061799-1FB49FE7-E18C-4715-9C3A-34736E832985Q38163001-1FB9D3C9-94D2-4139-AB84-6DA6BE6A1E87Q38259305-EE435C03-00AC-4497-917D-04298CCC4CB6Q38434603-F272E1B7-45BE-4A3B-BD05-340646A86BCEQ38471541-F1C539EF-9E42-4EAC-83C0-E8253B271EDEQ38780360-7E335A7A-46F0-44F5-9993-7244345D61A7Q41591129-58868700-0BEA-4934-9CCF-55D09D971B64Q41898952-6653D762-9AD6-4B70-A68B-1DF344661403Q42735728-D11593ED-E2D1-4AE5-BFE9-5BA8469717FFQ43690803-DE7D873D-8F2F-4013-99D0-D1308C2FCF3EQ44743116-28C807C5-CE7A-4BB0-8238-A9D524D6C545Q44971859-4584606D-985C-4963-8C77-791E852D1386Q46198509-A86DCB90-5D42-44AB-BE66-24C852743E71Q46611381-BA9A549F-2A17-4FA5-AC90-A97D0E74EB38Q46813458-815A2343-383E-445B-B33C-5BE22EEECA05Q46861181-76A01B8B-4D85-4122-8680-8FD12C5FC10EQ46904973-D4431C1C-419A-4E80-912C-822A4232E9F8Q49679592-32735148-8030-4223-BDD5-647D7C3E6D19Q51707319-0358E470-187D-4B09-9280-47363EBA2911Q53664550-D27E13D2-AFD8-451E-916D-9B3B0CDF8F9FQ55043209-3739B059-381A-4AA1-B4FF-A88722C7EFA1Q55128005-36DDB298-79D8-4F37-A3E0-83009CF19B92Q55279804-F6FD500A-4043-48C2-B7A8-DEB8630285ABQ58803514-F230394C-CDB0-400D-A144-D07663656974
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The antioxidant effects of statins.
@ast
The antioxidant effects of statins.
@en
type
label
The antioxidant effects of statins.
@ast
The antioxidant effects of statins.
@en
prefLabel
The antioxidant effects of statins.
@ast
The antioxidant effects of statins.
@en
P2093
P1476
The antioxidant effects of statins.
@en
P2093
Jean Davignon
R Preston Mason
Robert F Jacob
P304
P356
10.1097/01.MCA.0000131573.31966.34
P577
2004-08-01T00:00:00Z